Investments (Tables)

9 Months Ended

Sep. 30, 2020

Investments Debt And Equity Securities [Abstract]

Summary of Long-term Investments

Long-term investments are comprised of the following items:

	September 30, 2020		December 31, 2019
Equity investments at fair value	$	2,207	$	4,183
Equity investments under measurement alternative		14,738		14,954
Debt securities classified under available-for-sale method		5,765		5,047
Total other investments	$	22,710	$	24,184

Summary of Ownership Interests in Equity Method Investments

The Company’s ownership interests in its equity method investments as of September 30, 2020 and December 31, 2019 and (loss) gain from equity method investments for the nine months ended September 30, 2020 were as follows:

	Approximate	Carrying value		(Loss) gain from equity method investments for the nine months ended
	ownership %	September 30, 2020		September 30, 2020
Investment in Fluent	50%	$	5,147	$	(4,725	)
Investment in Cannfections	50%		3,764		230
Total equity method investments		$	8,911	$	(4,495	)

	Approximate	Carrying value		(Loss) gain from equity method investments for the nine months ended
	ownership %	December 31, 2019		September 30, 2019
Investment in Fluent	50%	$	7,836	$	(1,837	)
Investment in Cannfections	50%		3,612		—
Total equity method investments		$	11,448	$	(1,837	)

Summary of Financial Information for Equity Method Investments

Summary financial information for the Company’s equity method investments on an aggregate basis is as follows:

	September 30, 2020		December 31, 2019
Current assets	$	12,346	$	13,942
Noncurrent assets	$	5,205	$	4,987
Current liabilities	$	4,965	$	1,561
Noncurrent liabilities	$	—	$	—

	Nine months ended September 30,
	2020			2019
Revenue	$	4,854		$	—
Gross profit	$	2,032		$	—
Net loss	$	(8,991	)	$	(3,160	)